Bicara Therapeutics (BCAX) logo

BCAX earnings date, and what happened the last 4 times

Next report

Tue Nov 10

Quality Score today -6

Before the open, in 14 days. Expected: the company has not confirmed it.

BCAX closed higher after 2 of its last 4 reports. On average it closed -3.5% the session after a report.

The moment BCAX reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when BCAX reports, with its figures

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

What happened after BCAX's last 4 reports

BCAX's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 11, 20262026 · Before open7estimated-17.8%-14.3%
May 11, 20262026 · Before open9estimated-0.4%+1.5%
Mar 30, 20262026 · Before open7estimated+4.1%+3.6%
Nov 10, 20252025 · Before open0estimated+1.0%-4.8%
  • Aug 11, 2026, before the open: that session BCAX opened -17.8% and closed -14.3%, and five sessions on it stood -10.1%. Its Quality Score going in was 7 (Average), estimated.
  • May 11, 2026, before the open: that session BCAX opened -0.4% and closed +1.5%, and five sessions on it stood -10.4%. Its Quality Score going in was 9 (Average), estimated.
  • Mar 30, 2026, before the open: that session BCAX opened +4.1% and closed +3.6%, and five sessions on it stood +13.5%. Its Quality Score going in was 7 (Average), estimated.
  • Nov 10, 2025, before the open: that session BCAX opened +1.0% and closed -4.8%, and five sessions on it stood +1.0%. Its Quality Score going in was 0 (Below Average), estimated.

Across these 4 reports BCAX opened higher after 2 of 4 and closed higher after 2 of 4; on average it opened -3.3%, closed -3.5%, and stood -1.5% five sessions on. Its Quality Score is -6 today, against 7 going into its Aug 11, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -14.3% after the Aug 11, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see BCAX's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about BCAX's earnings

As of Oct 27, 2026: Bicara Therapeutics (BCAX): expected to report Tue Nov 10, before the open. BCAX closed higher after 2 of its last 4 reports. Its Quality Score is -6 (Poor). Scores as of 12:12 AM ET, 15 minutes behind.

When is BCAX's next earnings date?

Expected to report Tue Nov 10, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. BCAX closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does BCAX report before or after the market?

BCAX is expected to report Tue Nov 10, before the open. Its last 4 reports came before the open.

How did BCAX stock react to its last earnings report?

Aug 11, 2026, before the open: that session BCAX opened -17.8% and closed -14.3%, and five sessions on it stood -10.1%.

Does BCAX stock usually go up after earnings?

BCAX closed higher after 2 of its last 4 reports. On average it closed -3.5% the session after a report, after opening -3.3%. Past behavior, not a forecast.

Bicara Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Who reports this week: the earnings calendar.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.